Global Health Data Exchange - Discover the World's Health Data

Economics of switching to second-line antiretroviral therapy with lopinavir/ritonavir in Africa: estimates based on DART trial results and costs for Uganda and Kenya

Nav

General Info
Geography 
Kenya (KEN)
Uganda (UGA)
Coverage type 
Country
Time period covered 
01/2007 - 12/2011